Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2015-08-17

Clinical Trial Update: Safety Study of Inhaled Saline in Acute Lung Injury [Phase 1]

View source ↗

Summary

A Phase 1 safety study of inhaled saline for acute lung injury was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Inhaled normal saline (sodium chloride 0.9% solution)

Snippet

Sponsor: Mayo Clinic | Conditions: Pulmonary Edema | Phase 1 | Status: WITHDRAWN